Novartis CEO Joins Anthropic's Board Of Directors

2026-04-15 02:17:04

(MENAFN- Swissinfo) Anthropic has appointed Vasant Narasimhan, current CEO of Swiss pharma giant Novartis, as a member of its independent board of directors. The structure now has seven members, the US.-based AI company said. Select your language

Generated with artificial intelligence. Listening: Novartis CEO joins Anthropic's board of directors This content was published on April 15, 2026 - 16:56 2 minutes Keystone-SDA

Français fr Le CEO de Novartis intègre l'organe de surveillance d'Anthropic Original Read more: Le CEO de Novartis intègre l'organe de surveillance d'Anth

+Get the most important news from Switzerland in your inbox

The appointment was made in accordance with Anthropic's specific governance structure, the Long-Term Benefit Trust, as announced by the US company on Tuesday night. This is an independent body overseeing Anthropic's long-term direction, designed to protect the company's mission from short-term commercial pressures.

In February, the trust announced the appointment of former Microsoft boss Chris Liddell, who also served under Donald Trump's first presidency as White House deputy chief of staff for policy coordination and director of strategic initiatives.
More More AI and medicine Explainer: why Roche's supercomputer is a big deal
This content was published on Mar 26, 2026 Pharma companies are racing to acquire microchips and achieve the most powerful AI capacity in the industry. But drug development is tricky and AI talents scarce.
Read more: Explainer: why Roche's supercomputer is a big

MENAFN15042026000210011054ID1110987556

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.